NEWS FROM OUR LAB

February 2021

Our recent paper on ‘RetroBioCat as a computer-aided synthesis planning tool for biocatalytic reactions and cascades’ was highlighted on the cover of Nature Catalysis.

This amazing cover art was done by Verena Resch from @luminous_lab. She also designed this website!

February 2021

Professor Nicholas Turner was interviewed on ‘In the Active Site’ podcast

As part of Biotrans 2021, the scientists who are invited to give a lecture are interviewed. You can access the podcasts here http://biotrans2021.uni-graz.at/podcast.html

February 2021

PhD student James Marshall presented his work at the NextGenBiocat conference

James recently published his work on screening of metagenomic IREDs in Nature Chemistry. You can read the paper here https://www.nature.com/articles/s41557-020-00606-w

January 2021

Better late than never!

Our review on ‘Enzymatic late-stage modifications’ is out now: https://onlinelibrary.wiley.com/doi/10.1002/anie.202014931

This was a great collaborative effort with colleagues from AZ and the Flitsch group as part of our ‘Prosperity Partnership’ project and is Dr. Christian Schnepel’s first corresponding author paper!

January 2021

Lucian Pirvu joins our group as a Post-doctoral Research Assistant

Read more about him on our members page

Research

Get an insight into our fields of research

READ MORE

Members

Meet the members of the Turner Lab

READ MORE

Publications

Browse our publications

READ MORE

Book

Biocatalysis in Organic Synthesis: The Retrosynthesis Approach
by Nicholas J Turner, Luke Humphreys

READ MORE

PREVIOUS NEWS FROM OUR LAB

May 2020

Professor Nicholas Turner has been elected a Fellow of the Royal Society (FRS)

Fellows are elected based on excellence in science via a peer-review process and are thus some of the most eminent scientists from the UK.

Professor Nicholas Turner FRS | Professor of Chemical Biology

“I am absolutely thrilled to be elected a Fellow of the Royal Society and delighted to have the opportunity to publicly thank all of the researchers my group who together have enabled this achievement. We have also had a lot of fun on the way which is important. I am also grateful to the University of Manchester for establishing the Manchester Institute of Biotechnology which provides a world class environment and state-of-the-art facilities for our research.”

CoeBio3 phase IV continues with the start of six new PhD students

CoeBio3 is the The Centre of Excellence for Biocatalysis, Biotransformations and Biocatalytic Manufacture. http://www.coebio3.manchester.ac.uk/

The centre is based in Manchester but supports PhD students at the University of York, The University of Liverpool and the University of Bristol. The program is supported by industrial affiliates from Merck, GSK, Novartis, AstraZeneca and more….

Professor Nicholas Turner will lead a “Prosperity Partnership” for

Developing new biocatalytic technologies for chemical manufacturing in the pharmaceutical industry

 

This AstraZeneca, Prozomix and The University of Manchester Prosperity Partnership will bring together their expertise to design and develop novel chemical manufacturing technologies, based upon engineered biocatalysts, with the aim of producing new therapeutic complex molecules.

Achieving this goal will require the generation of a new toolbox of biocatalysts that are able to catalyse particularly demanding transformations. This project has the potential to bring new medicines to patients, in addition to developing more sustainable manufacturing processes that reduce the impact on the environment.

Prof Nicholas Turner | Professor of Chemical Biology
Securing this prestigious Prosperity Partnership grant represents a significant step forward for the University of Manchester Industrial Biotechnology Research Beacon and highlights the world leading research being undertaken within the Manchester Institute of Biotechnology.